Absci

Categories

Description

AI-driven platform for accelerating biologics drug discovery and development.

Summary

Absci is an AI-driven biotechnology company that aims to revolutionize the biologics drug discovery and development process. By leveraging generative AI and wet lab integration, Absci accelerates the design of differentiated biologics, including a TL1A antibody for Inflammatory Bowel Disease. Their platform supports novel target discovery through reverse immunology, enabling the rapid conception to clinic transition of biologics.

Use Cases

• Designing a differentiated TL1A antibody for Inflammatory Bowel Disease with a potential best-in-class profile.
• Partnering with pharma and academia to develop biologics against challenging targets.